EYPT
EyePoint Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -6.7% ·
aandelenstroom -8.9% ·
netto nieuwe posities -7.1%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 78 | +2 | 47.62M | $680.75M | +5 | −3 |
| Q1 2026 | 79 | +9 | 48.20M | $619.80M | +12 | −3 |
| Q4 2025 | 69 | +1 | 44.57M | $814.29M | +2 | −1 |
| Q3 2025 | 14 | -1 | 22.98M | $327.28M | — | −1 |
| Q2 2025 | 12 | 0 | 22.66M | $213.25M | — | — |
| Q1 2025 | 9 | -1 | 13.73M | $74.43M | — | −1 |
| Q4 2024 | 10 | 0 | 15.37M | $114.47M | +1 | −1 |
| Q3 2024 | 9 | -2 | 10.25M | $81.94M | — | −2 |
| Q2 2024 | 11 | — | 10.63M | $92.49M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 5.56M | -18.2% | $79.17M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 4.96M | -7.4% | $70.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 4.96M | -7.4% | $70.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 4.96M | -7.4% | $70.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 4.96M | -7.4% | $70.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 4.96M | -7.4% | $70.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 4.96M | -7.4% | $70.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 4.96M | -7.4% | $70.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 4.96M | -7.4% | $70.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 4.96M | -7.4% | $70.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 4.96M | -7.4% | $70.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (passief) | 3.79M | -0.2% | $54.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | The Vanguard Group ✦ (passief) | 3.79M | -0.2% | $54.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passief) | 3.79M | -0.2% | $54.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 2.14M | -8.9% | $30.41M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | Geode Capital Management ✦ (passief) | 1.52M | -4.2% | $21.71M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 17 | Geode Capital Management ✦ (passief) | 1.52M | -4.2% | $21.71M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | Goldman Sachs Group ✦ | 1.51M | — | $21.57M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Goldman Sachs Group ✦ | 1.51M | — | $21.57M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | State Street Global Advisors ✦ (passief) | 1.47M | -2.8% | $20.98M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 978.13K | — | $13.93M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 978.13K | — | $13.93M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 978.13K | — | $13.93M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 978.13K | — | $13.93M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 978.13K | — | $13.93M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Millennium Management ✦ | 483.05K | +1166.2% | $6.88M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 27 | Wellington Management ✦ | 215.45K | -18.7% | $3.07M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 28 | Wellington Management ✦ | 215.45K | -18.7% | $3.07M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 29 | Wellington Management ✦ | 215.45K | -18.7% | $3.07M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 30 | Two Sigma Investments ✦ | 179.44K | -52.4% | $2.56M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 31 | T. Rowe Price ✦ | 81.91K | -2.1% | $1.17M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 60.52K | — | $861,862 | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 60.52K | — | $861,862 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 60.52K | — | $861,862 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 60.52K | — | $861,862 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Fidelity (FMR) ✦ | 17.87K | -96.0% | $254,502 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 37 | Fidelity (FMR) ✦ | 17.87K | -96.0% | $254,502 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Renaissance Technologies | $348,170 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 40.00K aandelen, $515 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Director · 10.60K aand @ 4.93 · $52,258
Open-market verkopen (S)
Geen open-market insider-verkopen in ons dekkingsvenster.
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie